CD274 and pneumonitis: Finally, the PACIFIC trial, a large, randomized trial of definitive chemoradiation followed by durvalumab within 6 weeks of radiation, did not seem to increase the rate of Grade 3–4 pneumonitis, and the rate of ICI-related toxicity was similar to previous monotherapy PD1/PDL1 trials.